• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapid progression of NASH in childhood.

作者信息

Kohli Rohit, Boyd Todd, Lake Kathleen, Dietrich Kim, Nicholas Lynda, Balistreri William F, Ebach Dawn, Shashidhar Harohadli, Xanthakos Stavra A

机构信息

Cincinnati Children's Steatohepatitis Center, Division of Pediatric Gastroenterology, Hepatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

出版信息

J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):453-6. doi: 10.1097/MPG.0b013e3181a9387b.

DOI:10.1097/MPG.0b013e3181a9387b
PMID:20179647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2880161/
Abstract
摘要

相似文献

1
Rapid progression of NASH in childhood.儿童非酒精性脂肪性肝炎的快速进展
J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):453-6. doi: 10.1097/MPG.0b013e3181a9387b.
2
TNF-alpha as therapeutic target in NASH: tried, but not yet proven.肿瘤坏死因子-α作为非酒精性脂肪性肝炎的治疗靶点：已尝试，但尚未得到证实。
J Gastroenterol Hepatol. 2007 May;22(5):613-4. doi: 10.1111/j.1440-1746.2007.04953.x.
3
Nonalcoholic steatohepatitis: a study of 49 patients.非酒精性脂肪性肝炎：49例患者的研究
Hum Pathol. 1989 Jun;20(6):594-8. doi: 10.1016/0046-8177(89)90249-9.
4
Fatty liver hepatitis and cirrhosis in obese patients.肥胖患者的脂肪性肝炎和肝硬化
Am J Med. 1979 Nov;67(5):811-6. doi: 10.1016/0002-9343(79)90740-x.
5
NASH and cryptogenic cirrhosis: a histological analysis.非酒精性脂肪性肝炎和隐源性肝硬化：组织学分析。
Ann Hepatol. 2009 Oct-Dec;8(4):346-52.
6
Nonalcoholic steatohepatitis.
Can J Gastroenterol. 1999 Oct;13(8):639-40.
7
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.非酒精性脂肪性肝炎所致肝硬化与慢性丙型肝炎所致肝硬化的临床特征及转归比较
J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.
8
[Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
Z Arztl Fortbild (Jena). 1974 Mar 15;68(6):298-302.
9
[NASH -- nonalcoholic steatohepatitis].[非酒精性脂肪性肝炎]
Z Gastroenterol. 2003 Jan;41(1):77-90. doi: 10.1055/s-2003-36679.
10
Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.肝祖细胞激活、纤维化和肝内脂肪细胞因子在儿童非酒精性脂肪性肝病中的产生。
Hepatology. 2012 Dec;56(6):2142-53. doi: 10.1002/hep.25742.

引用本文的文献

1
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes.儿童代谢功能障碍相关脂肪性肝病对标准治疗的纵向反应：改善和恶化率以及与预后相关的因素。
Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001216.
2
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD.吡格列酮联合托吡酯治疗小儿重症 MASLD。
Saudi J Gastroenterol. 2024 Jul 1;30(4):252-259. doi: 10.4103/sjg.sjg_428_23. Epub 2024 May 10.
3
A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog.一例因促性腺激素释放激素类似物加重的中枢性性早熟合并非酒精性脂肪性肝炎病例
JPGN Rep. 2020 Sep 28;1(2):e014. doi: 10.1097/PG9.0000000000000014. eCollection 2020 Nov.
4
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.儿童脂肪性肝病（MAFLD/PeFLD 2型）：独特的分类考量与挑战
Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388. eCollection 2023.
5
In Utero Exposure to Persistent Organic Pollutants and Childhood Lipid Levels.子宫内暴露于持久性有机污染物与儿童血脂水平
Metabolites. 2021 Sep 28;11(10):657. doi: 10.3390/metabo11100657.
6
Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction.按肥胖程度分层，而不是按年龄分层，可以确定更高比例的儿童有患非酒精性脂肪肝和代谢功能障碍的风险。
Pediatr Obes. 2022 Mar;17(3):e12862. doi: 10.1111/ijpo.12862. Epub 2021 Oct 18.
7
Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review.非酒精性脂肪性肝病患儿纤维化检测的诊断准确性：系统评价。
Liver Int. 2021 Sep;41(9):2087-2100. doi: 10.1111/liv.14908. Epub 2021 May 11.
8
The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.过量饮食果糖摄入与儿童非酒精性脂肪肝的关系。
Pediatr Obes. 2021 Jun;16(6):e12759. doi: 10.1111/ijpo.12759. Epub 2020 Dec 11.
9
Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease?基线特征能否用于预测儿童非酒精性脂肪性肝病的肝脏疾病结局？
Obesity (Silver Spring). 2021 Jan;29(1):171-176. doi: 10.1002/oby.22999. Epub 2020 Nov 13.
10
Cirrhosis in a Young Child Due to Fatty Liver; Importance of Early Screening: A Case Report and Review of the Literature.小儿脂肪性肝病致肝硬化；早期筛查的重要性：病例报告及文献复习。
Am J Case Rep. 2020 Jun 25;21:e923250. doi: 10.12659/AJCR.923250.

本文引用的文献

1
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.非酒精性脂肪性肝病（NAFLD）中的门静脉慢性炎症：非酒精性脂肪性肝炎临床研究网络的晚期NAFLD组织学标志物——临床病理相关性
Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.
2
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.ELF血清标志物在预测儿童非酒精性脂肪性肝病纤维化阶段中的表现。
Gastroenterology. 2009 Jan;136(1):160-7. doi: 10.1053/j.gastro.2008.09.013. Epub 2008 Sep 20.
3
Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.减肥手术对非酒精性脂肪性肝病的影响：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1396-402. doi: 10.1016/j.cgh.2008.08.012. Epub 2008 Aug 19.
4
Disease progression in a patient with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的疾病进展。
J Formos Med Assoc. 2008 Oct;107(10):816-21. doi: 10.1016/S0929-6646(08)60196-5.
5
Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials.非酒精性脂肪性肝炎中的安慰剂：对自然史的洞察及对未来临床试验的启示
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1243-8. doi: 10.1016/j.cgh.2008.07.013. Epub 2008 Jul 25.
6
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.隐源性肝硬化中代谢综合征、肥胖症和2型糖尿病的患病率。
World J Gastroenterol. 2008 Aug 14;14(30):4771-5. doi: 10.3748/wjg.14.4771.
7
Fat luck: three siblings requiring liver transplantation for nonalcoholic steatohepatitis.
Transpl Int. 2008 Feb;21(2):189-91. doi: 10.1111/j.1432-2277.2007.00586.x. Epub 2007 Oct 18.
8
Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.接受Roux-en-Y胃旁路手术的病态肥胖患者肝脏左右叶之间的组织病理学变异性。
Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. doi: 10.1016/j.cgh.2007.06.005. Epub 2007 Aug 16.
9
Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study.超重儿童和青少年的心血管危险因素与肥胖：博加卢萨心脏研究
J Pediatr. 2007 Jan;150(1):12-17.e2. doi: 10.1016/j.jpeds.2006.08.042.
10
Prevalence of fatty liver in children and adolescents.儿童和青少年脂肪肝的患病率。
Pediatrics. 2006 Oct;118(4):1388-93. doi: 10.1542/peds.2006-1212.